{
    "2020-11-05": [
        [
            {
                "time": "",
                "original_text": "医药生物行业上市公司2020年三季报小结：疫情影响逐渐消退 关注高成长龙头+细分冠军",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "疫情",
                        "影响",
                        "消退",
                        "高成长",
                        "龙头",
                        "细分冠军"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗、健帆生物、戴维医疗纷纷下滑，医疗保健设备板块跌超1%",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "健帆生物",
                        "戴维医疗",
                        "下滑",
                        "医疗保健设备",
                        "板块",
                        "跌超1%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗保健设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}